Laddar...
Heterogeneity of kinase inhibitor resistance mechanisms in GIST
Most GIST patients develop clinical resistance to KIT/PDGFRA tyrosine kinase inhibitors (TKI). However, it is unclear whether clinical resistance results from single or multiple molecular mechanisms in each patient. KIT and PDGFRA mutations were evaluated in 53 GIST metastases obtained from 14 patie...
Sparad:
| Huvudupphovsmän: | , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2008
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2693040/ https://ncbi.nlm.nih.gov/pubmed/18623623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|